ArticleBMC rheumatology2019

Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: an update from the Australian Rheumatology Association Database (ARAD) prospective cohort study.

Margaret P Staples et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.